OTLCOTCPharmaceutical PreparationsFiscal year ends December 31
Oncotelic Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.02+0.00 (+11.45%)
Close on Oct 19, 2026
- Market cap
- $8.66M
- P/E (TTM)
- 0.0
- Dividend yield
- –
Ownership
Who owns Oncotelic Therapeutics's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
7 buys · 0 sales
Net bought $37.74K
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Anthony E. Maida Iii | DIRECTOR AND CMO - TRANS. MED. | 1,137,314 | 0.25% | Jul 14, 2026 |
| Vuong Trieu | CHAIRMAN AND CEO, Director, 10% owner | 117,777,232 | 25.74% | Jul 14, 2026 |
| Seymour Howard Fein | CRO/CMO | – | – | Jul 23, 2026 |
| Saran Saund | CBO | 16,457,480 | 3.60% | Jul 14, 2026 |
| Amit B. Shah | CFO | 378,837 | 0.08% | Jul 14, 2026 |
| Steven W. King | Director | 4,027,351 | 0.88% | Jul 21, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Vuong Trieu CHAIRMAN AND CEO, Director, 10% owner | Jul 1, 2026 | Buy | +240,000 | $0.04 | $9.60K | 94,124,319 |
| Vuong Trieu CHAIRMAN AND CEO, Director, 10% owner | Jun 24, 2026 | Buy | +115,000 | $0.05 | $5.75K | 93,884,319 |
| Vuong Trieu CHAIRMAN AND CEO, Director, 10% owner | Jun 23, 2026 | Buy | +75,000 | $0.05 | $3.75K | 93,769,319 |
| Vuong Trieu CHAIRMAN AND CEO, Director, 10% owner | Jun 22, 2026 | Buy | +65,000 | $0.05 | $3.25K | 93,694,319 |
| Amit B. Shah CFO | Jun 22, 2026 | Buy | +20,000 | $0.05 | $1.00K | 378,837 |
| Vuong Trieu CHAIRMAN AND CEO, Director, 10% owner | Jun 17, 2026 | Buy | +239,759 | $0.04 | $9.59K | 93,629,319 |
| Vuong Trieu CHAIRMAN AND CEO, Director, 10% owner | Jun 15, 2026 | Buy | +96,000 | $0.05 | $4.80K | 93,389,560 |
| Vuong Trieu CHAIRMAN AND CEO, Director, 10% owner | Jul 10, 2025 | Buy | +104,000 | $0.01 | $1.04K | 93,293,560 |
| Vuong Trieu CHAIRMAN AND CEO, Director, 10% owner | Jul 9, 2025 | Buy | +1 | $0.01 | $0 | 93,293,561 |
| Vuong Trieu CHAIRMAN AND CEO, Director, 10% owner | Jul 8, 2025 | Buy | +94,736 | $0.01 | $947 | 93,388,297 |
| Vuong Trieu CHAIRMAN AND CEO, Director, 10% owner | Jan 31, 2025 | Buy | +63,775 | $0.03 | $1.91K | 93,189,560 |
| Vuong Trieu CHAIRMAN AND CEO, Director, 10% owner | Jan 30, 2025 | Buy | +100,003 | $0.03 | $3.00K | 93,125,785 |
| Vuong Trieu CHAIRMAN AND CEO, Director, 10% owner | Jan 29, 2025 | Buy | +183,066 | $0.03 | $5.49K | 93,025,782 |
| Vuong Trieu CHAIRMAN AND CEO, Director, 10% owner | Nov 22, 2024 | Buy | +298,499 | $0.03 | $8.95K | 92,842,716 |
| Vuong Trieu CHAIRMAN AND CEO, Director, 10% owner | Aug 23, 2024 | Buy | +500,000 | $0.02 | $10.00K | 92,544,217 |
| Vuong Trieu CHAIRMAN AND CEO, Director, 10% owner | Jun 29, 2023 | Buy | +425,000 | $0.02 | $8.50K | 92,044,217 |
| Vuong Trieu CHAIRMAN AND CEO, Director, 10% owner | Jun 28, 2023 | Buy | +75,000 | $0.03 | $2.25K | 91,619,217 |
| Vuong Trieu CHAIRMAN AND CEO, Director, 10% owner | Jun 16, 2023 | Buy | +100,000 | $0.03 | $3.00K | 91,544,217 |
| Vuong Trieu CHAIRMAN AND CEO, Director, 10% owner | Jun 14, 2023 | Buy | +400,000 | $0.03 | $12.00K | 91,444,217 |
| Vuong Trieu CHAIRMAN AND CEO, Director, 10% owner | May 26, 2023 | Buy | +126,888 | $0.03 | $3.81K | 91,044,217 |
| Vuong Trieu CHAIRMAN AND CEO, Director, 10% owner | May 2, 2023 | Buy | +100,000 | $0.05 | $5.00K | 90,917,329 |
| Vuong Trieu CHAIRMAN AND CEO, Director, 10% owner | Dec 6, 2022 | Buy | +120,000 | $0.05 | $6.00K | 90,558,021 |
| Vuong Trieu CHAIRMAN AND CEO, Director, 10% owner | Nov 22, 2022 | Buy | +70,000 | $0.08 | $5.60K | 90,438,021 |
| Vuong Trieu CHAIRMAN AND CEO, Director, 10% owner | Sep 26, 2022 | Buy | +20,000 | $0.07 | $1.40K | 90,368,021 |
| Vuong Trieu CHAIRMAN AND CEO, Director, 10% owner | Aug 25, 2022 | Buy | +80,000 | $0.08 | $6.40K | 90,348,021 |
| Vuong Trieu CHAIRMAN AND CEO, Director, 10% owner | Jul 8, 2021 | Award | +259,302 | – | – | 90,527,323 |
| Amit B. Shah CHIEF FINANCIAL OFFICER | Jul 8, 2021 | Award | +298,837 | – | – | 358,837 |
| Saran Saund CHIEF BUSINESS OFFICER | Jul 8, 2021 | Award | +102,519 | – | – | 16,457,480 |
| Anthony E. Maida Iii CHIEF CLINICAL OFFICER, Director | Mar 31, 2021 | Conversion | +938,646 | – | – | 1,137,314 |
| Vuong Trieu CHAIRMAN AND CEO, Director, 10% owner | Mar 31, 2021 | Conversion | +5,672,025 | – | – | 6,872,529 |
| Vuong Trieu CHAIRMAN AND CEO, Director, 10% owner | Mar 31, 2021 | Conversion | +13,849,161 | – | – | 16,780,384 |
| Vuong Trieu CHAIRMAN AND CEO, Director, 10% owner | Mar 31, 2021 | Conversion | +74,455,719 | – | – | 90,268,021 |
| Steven W. King Director | Mar 31, 2021 | Conversion | +3,291,720 | – | – | 3,330,647 |
| Saran Saund CHIEF BUSINESS OFFICER | Mar 31, 2021 | Conversion | +16,354,961 | – | – | 16,354,961 |
| Amit B. Shah CHIEF FINANCIAL OFFICER | Nov 24, 2020 | Buy | +8,220 | $0.19 | $1.56K | 60,000 |
| Amit B. Shah CHIEF FINANCIAL OFFICER | Nov 23, 2020 | Buy | +20,088 | $0.19 | $3.82K | 51,780 |
| Amit B. Shah CHIEF FINANCIAL OFFICER | Nov 20, 2020 | Buy | +31,692 | $0.20 | $6.34K | 31,692 |
| Vuong Trieu CHIEF EXECUTIVE OFFICER | Nov 19, 2020 | Buy | +50,500 | $0.19 | $9.60K | 15,812,308 |
| Chulho Park CHIEF TECHNOLOGY OFFICER | Nov 19, 2020 | Buy | +22,173 | $0.18 | $3.99K | 2,833,992 |
| Vuong Trieu CHIEF EXECUTIVE OFFICER | Mar 26, 2020 | Buy | +3,000 | $0.12 | $360 | 15,761,808 |
| Matthew M. Loar Chief Financial Officer | Apr 12, 2018 | Buy | +250,000 | – | – | 300,000 |
| Donald Rogers Reynolds Director | Apr 12, 2018 | Buy | +250,000 | – | – | 280,000 |
| William D. Schwieterman President and CEO, Director | Apr 12, 2018 | Buy | +625,000 | – | – | 625,747 |
| Donald Rogers Reynolds Director | Dec 16, 2016 | Buy | +12,700 | $0.34 | $4.32K | 12,700 |
| Donald Rogers Reynolds Director | Dec 16, 2016 | Buy | +9,950 | $0.36 | $3.58K | 30,000 |
| Donald Rogers Reynolds Director | Dec 16, 2016 | Buy | +7,350 | $0.35 | $2.57K | 20,050 |
| Gerald McMahon PhD Director | Jul 2, 2014 | Award | +3,847 | – | – | 18,611 |
| Gerald McMahon PhD Director | Jan 2, 2014 | Award | +3,584 | – | – | 14,764 |
| Peter Langecker Chief Executive Officer, Director | Aug 8, 2013 | Award | +72,993 | – | – | 77,993 |
| Gerald McMahon PhD Director | Jul 1, 2013 | Award | +7,407 | – | – | 11,180 |
| Tamar D. Howson Director | Jul 1, 2013 | Award | +3,703 | – | – | 8,761 |
| Peter Langecker Chief Executive Officer, Director | Jun 28, 2013 | Buy | +3,000 | $2.75 | $8.25K | 5,000 |
| Peter Langecker Chief Executive Officer, Director | Jun 25, 2013 | Buy | +2,000 | $2.79 | $5.58K | 2,000 |
| Tamar D. Howson Director | Jan 2, 2013 | Award | +1,886 | – | – | 5,058 |
| Gerald McMahon PhD Director | Jan 2, 2013 | Award | +3,773 | – | – | 3,773 |
| Tamar D. Howson Director | Jul 2, 2012 | Award | +18,148 | – | – | 38,060 |
| Tamar D. Howson Director | Jul 1, 2012 | Award | +18,148 | – | – | 38,060 |
| Tamar D. Howson Director | Jan 2, 2012 | Award | +10,101 | – | – | 19,912 |
| Tamar D. Howson Director | Oct 31, 2011 | Award | +6,061 | – | – | 9,811 |
| Alastair JJ Wood Director | Oct 31, 2011 | Award | +12,121 | – | – | 17,871 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.